|
|
||
January 14, 2011Volume 3 Issue 1 |
|
|
|
In This Issue· Stem Cell Victories of the Month
· Progress in Repair Stem Cell Science
· Heart and Soul: Stem Cells for Heart Patients
· Fighting PhRMA Stem Cell Propaganda
Don Margolis
Bangkok, Thailand |
I - STEM CELL VICTORIES OF THE MONTH
New Hope for Saving Diabetic Foot from Amputation
- Two autologous stem cell therapy sessions prevented patient from foot amputation
LOS ANGELES, Dec. 24, 2010 / -- During ICMS (International Cellular Medicine Society www.cellmedicinesociety.org) Annual International Congress on Regenerative and Cell Based Medicine Conference held on November 12, 2010 in Las Vegas, Nevada, it was announced that a patient with complications of diabetes-gangrene recovered from foot ulcer through stem cell therapy.
Patient, Sun Rae Cho (age 72 from Chungbuk, South Korea) who suffered from complications of diabetes for 17 years, received stem cell treatment. Cho experienced remarkable effects such as healed ulcers and improvement of tingling sensation on feet last September.
After Cho was diagnosed with diabetes mellitus in 1993, he had to wear an insulin pump in suffering day to day. Due to these complications, Cho's five toes began to swell and change color last May. There became increasingly large areas of pus and deep wounds on his feet. He was told by doctors that his legs would have to be amputated. There is no other option for Cho's gangrenous condition. |
|
|
Cho agreed to having surgery for his leg amputation at a local hospital in Seoul, Korea last September. Fortunately, it was suggested he seek treatment with his preserved stem cells. He traveled to China and Japan for infusions of 300 million stem cells into each foot.
Just 10 days after Cho's stem cell injection, there was 70-80% improvement in pus and wounds; an improvement of 90% was exhibited 20 days later. As the wounds began to heal, the pain and tingling was no longer evident.
SEE HUNDREDS MORE OF THESE TRUE STORIES, ARRANGED BY DISEASE SO YOU CAN CONCENTRATE ON THE ILLNESS OF YOUR LOVED ONE. www.donrmargolis.com
II - PROGRESS IN REPAIR STEM CELL SCIENCE
“Cell Transplantation” reports a success in treating end-stage liver disease Ed Note: Don Margolis has seen it all and is never surprised at any new Repair Stem Cell “Miracle,’---until now! He said. “We have seen so many failed attempts at saving hepatic liver failure patients from transplants and death. Then suddenly this appears out of nowhere. It will not be available in North America for 10-20 years for reasons our readers know well, but maybe Asia or Latin America by 2015.” A bit technical, but worth the read.---Ed Tampa, Fla. (Jan. 10, 2011) – Transplanting their own (autologous) bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation (19:11). Yet, the mechanism by which the infusion of CD34+ stem cells improves liver function remains elusive, they say. The study, carried out by a team of researchers in California and in Egypt, is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/. According to the study's corresponding author, Dr. Mark A. Zern of the University of California Davis Medical Center, Sacramento, CA, patients with end-stage liver failure in Egypt have few treatment options but for transplantation. A shortage of donors and cost factors make that strategy unrealistic. Accordingly, this study sought to evaluate the safety and efficacy of transplanting autologous bone marrow-derived CD34+ stem cells in 48 patients, 36 of whom had chronic, end-stage hepatitis C-induced liver disease, and 12 with end-stage autoimmune liver disease. "For all patients there was a statistically significant decrease in peritoneal cavity fluid, or 'ascites,'" said Dr. Zern. "There was also clinical and biochemical improvement in a large percentage of patients who received the transplantation." The researchers reported that they obtained "reasonable numbers of CD34+ cells" that were then "amplified and partially differentiated into hepatocyte precursor cells." "This enabled us to transplant as many as one billion of these cells per patient," explained Dr. Zern. "The use of peripheral infusion would dramatically reduce both costs and risks for this cell transplantation, thus making the treatment an even more viable option in Egypt and throughout the world," concluded Dr. Zern. "It would be very interesting to determine if the differentiation to hepatic precursors was a necessary step for this treatment," said Dr. Stephen Strom, a professor of pathology in the Department of Pathology at the University of Pittsburgh and section editor for Cell Transplantation. "Other research groups are now showing similar results with cells without any hepatic characteristics, including fractionated and unfractionated bone marrow and mesenchymal stem cells. Taken together, these data suggest that the positive effects these researchers find may be the result of paracrine effects from factors secreted by the donor cells. I look forward to reading about the outcome of future studies to determine the optimal route of administration and dose of these cells, as well as more long term follow up." ### Contact: Dr. Mark A. Zern, UC Davis Medical Center, 4635 Second Ave. Ste. 1001, Sacramento, CA ?Tel: (916) 734-8063; Fax: (916) 734-8097 ?Email: mazern@ucdavis.edu Citation: Salama, H.; Zekri, A-R..; Zern, M.; Bahnassy, A.; Loutfy, S.; Shalaby, S.; Vigen, C.; Burke, W.; Mostafa, M.; Medhat, E.; Alfi, O.; Huttinger, E. Autologous Hematopoietic Stem Cell Transplantation in 48 Patients With End-Stage Chronic Liver Diseases. Cell Transplant. 19(11):1475-1486; 2010.
III - HEART AND SOUL:STEM CELLS FOR HEART PATIENTSBut I don’t WANT a transplant!
Heart disease, according to the figures from The National Center for Health Statistics, affects some 25.6 million Americans. It is the biggest killer of U.S. citizens, with about 650,000 dying every year. Until now, patients deteriorated as dozens of pills and surgeries on their heart failed to help, they were faced with only two options, a heart transplant or death.
VesCell, an international biotechnology company based in Israel, has shown the world that it can provide a realistic third option that offers new hope to heart failure patients, whether or not ischemic - treatment with their own adult stem cells. Their patented therapy uses a mere half pint of the patient's own blood from which millions of adult stem cells are grown then implanted into the damaged heart muscle or occluded heart blood vessels.
Most of their 500 treated patients---70%--- have attested to the fact that their lives have been improved by this technique which is performed by cardiac specialists in world-class hospitals using a simple catheter implant
Terry Areford from Morgantown, West Virginia is just one patient who was not told by his cardiologist that the option of adult stem cell therapy existed for him. More appalling than not being so advised, he was a patient at the prestigious teaching hospital attached to the University of West Virginia where he could reasonably have expected to receive the best and most advanced treatment options available to medical science. He believed that his imminent death was unavoidable because he did not want a transplant. But after several heart attacks, six bypasses and more than half a dozen operations to insert stents he had only one small vessel left pumping blood to the front of his heart.
Daily living for Terry was characterized by pain and shortness of breath. He could not walk a hundred feet without tightness in his chest. At only 60 years of age in 2007, Terry felt that he would like to be around a little longer to enjoy his family and grandchildren. He was upset and felt that there ought to have been more that could be done to help him. Fortunately for him, his daughter was internet savvy and searched until she found that there were, indeed, grounds for hope.
'I think it's a total shame that I cannot get the help I need at home. I found out that there is some research going on with adult stem cells in the U.S. but they are like five year trials. I couldn't wait five years. There's going to be a lot of people dead in five years and they wouldn't have to be dead if they knew about adult stem cell therapy,' he said.
'I hope ten people read my story and go out and tell ten more people so that everybody comes to understand what this is all about. I was using my own body to help, or perhaps cure, my own body. There is no rejection factor and it took only a small incision in my chest wall and an injection of my own stem cells into the heart. Once implanted these cells do what they are programmed to do - revascularize to improve blood flow to my useless heart muscle. “While my wife shopped and visited the local markets, I lay back in a superb hospital with fantastic care to get well,” he added.
Today, Terry is 63 and in his 4th year post stem cells. See his video from 2007 at www.vescell.com/videos.htm --he’s the third one in the left column. He’s still doing well in 2011. You may email him at bkareford@msn.com. He won’t mind if you wish to chat with him.
Ed Note: Five years ago a New Jersey lady was told to get a transplant. She got VesCell stem cells instead. After five years of success the stem cells stopped helping and this time she was “forced” to get the transplant. Next issue you can read her word-for-word report. Unfortunately her heart is not as strong as her exceptional writing skills!
IV - LAB RAT REPORT FOR THE WEEKWe have just one purpose with these long multiple Lab Rat reports---to help YOU save yourself and your loved ones from harmful drugs and deadly therapies your doctors earn commissions and “referral fees” on. They always win, you lose usually.
PhRMA has graduated from developing useless drugs for existing diseases to developing fictional diseases in order to sell useless drugs…as the FDA looks the other way.
It was just a few years ago that two super-corrupt institutions, PhRMA and Harvard, conspired to create a new disease for children who were not yet good customers. PhRMA had a drug no one needed, so Harvard created the disease. When caught, they laid the blame on the guy that got a couple million to write the fiction, but today thousands of crooked doctors all over the world earn commissions to make drug-users out of pre-kindergarden kids for a fictional “disease” created by Harvard.
Since then, PhRMA got the FDA (which it owns) to ALLOW this disease-creation. Now all they have to do is convince the insurance companies, which as Michael Moore and others point out, are the ONLY decision makers as to what medicines you lab rats are allowed to take. Know that if it is not profitable to the big medicine billionaires, YOU cannot legally use it---so die suckah!
Naturally, all the commission-earning doctors (75%) in North America will make tens of millions pushing the pills on a drug-abusing population. These whores-for-PhRMA are the same ones who lie to desperate patients who are dumb enough to ask one of THEM about stem cells: “Stem cells don’t work, but why don’t you try this new pill that just came out?”
So what is the latest “new disease” of your legal drug-pushers?
Pharma's New Sales Pitch to Women: If You Aren't Horny, It's 'Sexual Dysfunction' -- Try These Pills How drug companies plan to profit from so-called 'Female Sexual Dysfunction.' AlterNet December 23, 2010 |
The woman looking confidently into the camera lens must be in her late twenties or early thirties, her long black hair falling over strong shoulders, a slip of striped blue material tied into a bow around her neck. Her red lips and good looks are striking, but it's her words that are most captivating. Her name is Darby Stephens, and she's a research manager at a California-based drug company called Vivus. The company is testing a drug for women said to suffer from a new condition called female sexual dysfunction or FSD. As Darby Stephens explains in an extremely candid on-camera interview for a documentary, FSD is so new that the drug company itself has had to help work out what the condition actually is: 'In order for us to develop drugs, we need to better and more clearly define what the disease is,' she said. The frankness of the comments may be unusual, but the marketing activity being described is becoming commonplace.
ED NOTE: As we mention above, it is no longer a criminal activity as it was in Harvard’s day under the spotlight. It is much easier being a criminal when you own the FDA.
Pharmaceutical companies now assist in shaping the very diseases their drugs are targeting. Through its close ties to (and 100% control over) the so-called “medical profession” and its influence over public debate, the industry is now helping to determine whether we see our sexual problems as every day difficulties or medical dysfunctions, and whether female sex drugs become a permanent feature in the bedrooms of our future. Want to guess how it will come out?
READ THE FULL STORY: http://www.alternet.org/story/149318/pharma%27s_new_sales_pitch_to_women%3A_if_you_aren%27t_horny%2C_it%27s_%27sexual_dysfunction%27_--_
THE LAB RAT ARTICLE OF THE MONTH 46% OF LAB RATS WERE MURDERED AND THEY HAD NO CLUE THAT THEY WERE IN AN FDA-APPROVED TRIAL
Ed Note: “If you got the bribes, the FDA will do anything you wish, and no one has more bribe money than Baxter International. They (and others) bribed the FDA only three years ago to ignore their poisonous stents. Today, thousands die from them every year and nobody can prove it. (“The patient died of heart disease, which he has had for years.”) So killing a mere 24 non-informed lab rats is nothing to them.”
A major company (that means ‘run by billionaires’) conducted an ill-fated blood-substitute trial without the informed consent of patients in the study - some of whom died, federal officials say. Baxter International was able to test the substitute known as HemAssist without consent because of a 1996 “change” in Food and Drug Administration (FDA) regulations.
The changes broke a 50-year standard to get consent for nearly all experiments on humans. They were designed to help research in emergency medicine that could not happen if doctors took the time to get consent. But the problems with the HemAssist trial are prompting some medical ethicists to question the rule change. "People get involved in something to their detriment without any knowledge of it," George Annas, a professor of health law at the Boston University School of Public Health, told the Chicago Tribune. "We use people. What's the justification for that?"
No other company has conducted a no-consent experiment under the rule, FDA officials said. ED NOTE: A huge lie.
Baxter officials halted their clinical trial of HemAssist after reviewing data on the first 100 trauma patients enrolled in the nationwide study.
Of the 52 critically ill patients given the substitute, 24 died, representing a 46.2 percent mortality rate. There has been an intense push to find a blood substitute because artificial blood could ease the effects of whole-blood shortages. Researchers say artificial blood lasts longer than conventional blood, eliminates the time-consuming need to match blood types and wipes out the risk of contamination with HIV, hepatitis or other viruses.
See http://web.archive.org/web/20080331212315/www.clarion.edu/academic/adeptt/bpcluster/cases.htm for a list of the USA hidden atrocities against you lab rats 1940-1980.
It became even more important because of U.S.-backed syphilis experiments on blacks in the South that went on for decades after a cure for the disease was revealed. Today it is social economical discrimination, rather than color or religion.
No lawsuits have arisen from the blood-substitute trial, Baxter officials said. "The regulations worked in this instance," company spokeswoman Mary Thomas said. "We voluntarily stopped the trial early on at the first sign of unexpected results to ensure patient safety."
FINAL NOTE FROM DON: What really worries me is that Baxter is paying for the biggest stem cell heart clinical trial in USA history. Of course the results are good through phase 2, but knowing who these guys are, it is almost for sure they will NEVER allow stem cells to be used on real patients and interfere with their billions in stent and other useless and/or dangerous products. Phase III should be over by 2014-15, but again, knowing them, I doubt it. When I questioned the eminent doctor in charge about this, he ran for the hills rather than respond. I don’t blame him.
IGNORANT PARENTS AND NON-CARING DOCTORS ARE DOOMING YOUNG LAB RATS TO CANCER
(Reuters) - Children and teens often get diagnostic tests that expose them to radiation, increasing the risk of cancer later in life, U.S. researchers said on Monday. Chest CTs delivers more than 100 times the radiation dose of a chest X-ray---and 8% of kids got one—3.5% got TWO! "In just a three-year span, 42.5 percent of kids got some form of ionizing radiation from a diagnostic medical procedure," said Dr. Adam Dorfman, a pediatric cardiologist at the University of Michigan in Ann Arbor, whose study appears in the Archives of Pediatrics and Adolescent Medicine. The study is among the first to look at radiation exposure among children and teenagers, who have the biggest long-term cancer risk from early and repeated exposure to radiation. Dorfman's team studied health claims data on more than 355,000 children and teens under age 18 who were covered by UnitedHealth Group, a large U.S. health insurer. "Nearly eight percent got at least one CT scan, and 3.5 percent got at least two CT scans in those three years," Dorfman said in a telephone interview. Radiation exposure became a major concern in October 2009 after the U.S. Food and Drug Administration said it was investigating more than 2,000 cases in which patients received toxic doses of radiation during CT scans of the brain at a California hospital. In children, the biggest risk from radiation exposure is cancer, although almost any body system can be affected, Dorfman said. For the full article: http://www.reuters.com/article/idUSTRE7023VZ20110103
V - FIGHTING PhRMA’S STEM CELL PROPAGANDATo remind you of Don’s 4 rules of medicine which are LAW in North America: 1—Profits for PhRMA, HMO’s, Insurance Companies, and Medical Device companies---every one worth multi billions---are all that matters. 2---No cures of ANY chronic disease are allowed EVER; because cures reduce profits. 3---Patients are Lab Rats to buy harmful and deadly “medical” treatments, mostly with our tax money or insurance money. Whether the treatments and drugs really work, or kill with side effects, is of no concern to anyone, especially the FDA. 4—The greatest threat to those profits is the science of Repair (adult) Stem Cells. They will stop at nothing to keep them from you. No lie is too big. No bribe is too big. They can and do spend a hundred million a year, almost all in bribes, keeping stem cells which work AWAY FROM YOU.
EVERY NATIONAL AND STATE PATIENT GROUP IS A DRUG-PUSHING CON FUNDED BY PhRMA
The NATIONAL ALLIANCE ON MENTAL ILLNESS is a phony group of scumbags pretending to care about patients while making tens of millions from PhRMA to bribe state and national legislators into allowing doctors to force any kind of poisonous drugs into helpless mental patients---and you suckers are paying the bills!
BUT DON’T TAKE OUR WORD FOR IT. LET’S LET THE WALL STREET JOURNAL TAKE THIS EASY PITCH!
Mental Health Group’s State Chapters Get Millions From Pharma By Katherine Hobson, Wall Street Journal
State chapters of the National Alliance on Mental Illness (NAMI) received several million dollars in contributions from PhRMA in a little less than five years, with big donations from Eli Lilly, AstraZeneca and Bristol-Myers Squibb, according to a letter from Sen. Charles Grassley. Grassley has made a project out of probing the financial ties of drug makers to nonprofits and academics, and last fall requested that state NAMI chapters disclose their donations. That was on the heels of his finding that drug makers gave the national group almost $23 million between 2006 and 2008, as the New York Times reported. The national group now has an online database of funding sources.
The NYT described the organization as “hugely influential in many state capitols” for its lobbying efforts to keep states from putting any restrictions on the drugs that can be prescribed to patients covered under Medicaid and other government-funded programs. Grassley has been interested in any financial support that comes from the makers of such drugs.
FOR THE FULL WSJ ARTICLE: http://blogs.wsj.com/health/2010/04/28/mental-health-groups-state-chapters-get-millions-from-pharma/
ED NOTE: Be sure to read the public comments at the bottom of that article. Each and every one of them COULD have been written by Don!
VI - THE EMBRYONIC HOAXFeminists finally wake up to the truth
Stem cell research is exploitative The hoax has us believing this is about science vs. religion, but it is nothing of the sort. It is about the religion of science.
There is another essential, less discussed facet of this issue that is always overlooked — the exploitation of women. Because this research requires human eggs, this is a woman’s issue. A common myth is that “leftover” embryos from fertility clinics are used for this research. In fact, consent of the parents is required and it’s rarely given. Less than 3 percent of embryos are approved for research by the real “parents.”
Needing to acquire the massive amount of eggs necessary, and lacking volunteers, researchers are now offering payment to women to undergo the extensive process to produce hyper-ovulation followed by surgical egg harvesting. These procedures involve a series of hormonal injections ending with surgery to remove as many eggs as possible. Potential complications include ovarian hyper-stimulation syndrome, infertility and ovarian trauma.
The Empire State Stem Cell Board has received approval to use taxpayer funds to pay women between $5,000 and $10,000 for “donating” their eggs. Because the practice is largely unregulated with little data on long term effects on young, presumably fertile women, participants are NOT given adequate information to make an informed decision---because there IS none!
ONLY THE ALREADY-EXPLOITED POOR Concerned about the exploitation of economically vulnerable women, Feminists Choosing Life of New York has filed a lawsuit against the ESSCB in hopes of preventing this gross misuse of taxpayer funds and preserving the health and dignity off all women, particularly the poor. For the full article: http://rocnow.com/article/essays/201012260339
VII - ATTENTION ASIANS1---RSCI has signed up one of Thailand’s leading stem cell doctors. They specialize in muscular-skeletal conditions such as arthritis, muscle, cartilage, tendons, discs etc. For North Americans, Maryland is still #1.
2—ANOTHER FULLY LICENSED USA CELLULAR DOCTOR IN THAILAND is treating Cancer, Diabetes, and the very wicked Fibromyalgia. Cost IS $17,000 for two weeks of intense, no-side-effect cell therapy (not stem cells) plus food and airfare.
3—THAILAND’S TOP PLASTIC SURGEON uses stem cells about half the time. Unfortunately his waiting list is six weeks, but from his results, it is worth the wait. About $10,000 to $12,000 for most patients
For further info, email don@repairstemcells.com
SUPER STEMMYS – DORIS AND THE SUPERCELLS |
||
|
www.repairstemcells.com |
www.donrmargolis.com |
|
|
LEGAL DISCLAIMER This
Newsletter is for educational purposes only and not to be taken as medical
advice. |
||
